We introduce ourselves
Our cell line development timelines and innovation are unprecedented. This is our focus, which is why we do it best. Ultimately, we help companies get drugs to patients faster and more cost-effectively.
Selexis SA is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines. Our global partners are utilizing Selexis technologies to advance more than 130 drug products in clinical development and the manufacture of seven commercial products. As part of a comprehensive drug development process, the Company’s technologies shorten development timelines and reduce manufacturing risks. In June 2017, Selexis became part of the JSR Life Sciences group. JSR’s CDMO service offering leverages the full capabilities of Selexis’ proprietary SUREtechnology Platform™ to offer an end-to-end solution to industry.
The Selexis SUREtechnology Platform™ improves the way mammalian cells are used in the discovery, development and manufacturing of recombinant proteins and drugs.
